(Q38070757)

28 August 2017

1 reference

title

SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma (English)

1 reference

Lambert-Eaton myasthenic syndrome

28 August 2017

main subject

1 reference

Alexander F Lipka

1

1 reference

28 August 2017

Jan J G M Verschuuren

series ordinal

2

1 reference

28 August 2017

Maarten J Titulaer

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 December 2012

1 reference

Annals of the New York Academy of Sciences

28 August 2017

published in

1 reference

28 August 2017

volume

1275

1 reference

28 August 2017

page(s)

70-77

1 reference

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Lambert-Eaton myasthenic syndrome: tumor versus nontumor forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Transient neonatal Lambert-Eaton syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Smoking and lung cancer survival: the role of comorbidity and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Antibodies and neuronal autoimmune disorders of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Paraneoplastic Syndromes Involving the Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Expression of Sox1, Sox2 and Sox9 is maintained in adult human cerebellar cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

SOX after SOX: SOXession regulates neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Immunobiomarkers in small cell lung cancer: potential early cancer signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Clinical validation of an autoantibody test for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Lambert-eaton myasthenic syndrome: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2012.06772.X

10.1111/J.1749-6632.2012.06772.X

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference